Pharmaron · 2 months ago
Facilities Technician II
Pharmaron is a global CRO helping pharma and biotech companies bring new therapies to life. The Facilities Technician II will be responsible for maintaining essential building systems that support scientific research operations, including installation, inspection, repair, and maintenance of various systems in site buildings.
BiotechnologyChemicalPharmaceutical
Responsibilities
Respond promptly to all facility tickets, facilitating timely resolution
Install, inspect, repair, and maintain electrical, plumbing, mechanical, and other related systems in all site buildings
Regularly inspect, operate, and maintain the site's HVAC systems to ensure compliance with local and federal regulations for animal facilities
Assist in renovations of existing facilities and other projects
Maintain comprehensive repair records and other paperwork in compliance with GMP/GLP, AAALAC, and USDA standards
Ensure proper usage, maintenance, and storage of facilities tools and supplies
May assist in the development of the departmental budget
Perform any other related duties as assigned
Qualification
Required
High school diploma or General Education Degree (G.E.D.)
3-5 years of related experience in general building maintenance with a mechanical and construction background
Certification/Licensure: Current, valid motor vehicle operator's license required
Preferred
Certification in a relevant trade (e.g., HVAC, electrical, or plumbing) preferred
Benefits
Insurance including Medical, Dental & Vision with significant employer contributions
Employer-funded Health Reimbursement Account
Healthcare & Dependent Care Flexible Spending Accounts
100% Employer-paid Employee Life and AD&D Insurance, Short- and Long-Term Disability Insurance
401k plan with generous employer match
Access to an Employee Assistance Program
Company
Pharmaron
Pharmaron is a contract research organization that offers research and development services for the life science industries.
Funding
Current Stage
Public CompanyTotal Funding
$907.82MKey Investors
GL Capital
2019-11-22Post Ipo Equity· $587.82M
2019-01-28IPO
2015-12-14Series Unknown· $280M
Recent News
2026-01-16
Precedence Research
2025-11-07
Business Wire
2025-10-29
Company data provided by crunchbase